Contract manufacturer introduces injection device featuring adjustable parameters and streamlined assembly process.

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval ...

Now, the Chicago-based pharma is heading southwest as it charts the next leg of its stateside investment tour.

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...

Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...

The business of manufacturing never stops. Industrial companies merge, invest and strategically expand to keep competitive, ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

A new shot is helping protect more babies from RSV. A Dayton doctor said it is already dramatically reducing hospitalizations ...

If you think SAST and SCA are enough, you’re already behind. The future of app security is posture, provenance and proof, not ...

Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...

Explore the challenges and strategies for securing AI integration in manufacturing, focusing on governance, data privacy, and ...